Federal and state Medicaid officials should widen access to prescription drugs that could cure tens of thousands of people with hepatitis C, including medications that can cost up to $1,000 a pill, health care experts have told the White House

Quick Read

Public reporting and shared savings distributions. Authors, including our Matthew DeCamp, MD, PhD, Analyze publicly reported organizational characteristics, shared savings distribution plans, and early financial success of accountable care organizations in the Medicare Shared Savings Program

Quick Read

One of the top providers of gene-sequencing technology, Illumina, is teaming up with investors in hopes of buttressing the growing universe of genetic analysis businesses

Quick Read

All Hat, No Cattle

August 18, 2015

The false hope of right-to-try laws. Alison Bateman-House & Arthur Caplan write: “Are right-to-try laws a good idea? In 2014, they began appearing throughout the United States, first in Colorado and now in 23 states, with several more considering passing versions of this popular legislation.”

Quick Read

Fetal Tissue Fallout

August 13, 2015

Alta Charo: “We have a duty to use fetal tissue for research and therapy.”

Quick Read

More than half of large employers in 2016 will aim to more tightly manage employees’ use of high-priced specialty drugs, one of the fastest-growing expenses in their health plans

Quick Read

No Easy Feat

July 30, 2015

Promoting the PrEP pill for HIV prevention among Latinos. “It hasn’t really hit the Latino community yet,” Jesse Hinostroza, an HIV prevention specialist with AltaMed health clinics, said while sitting at a table with a bowl of condoms and a stack of bilingual pamphlets about the pill. “They aren’t educated about it”

Quick Read

Lawsuit claims price guidelines used by fertility clinics artificially suppress the amount women can get for their eggs

Quick Read